今天,我们来看看这本SCI期刊:Circulation-Genomic and Precision Medicine。从现有的记录来看,Circulation-Genomic and Precision Medicine 的2022年影响因子(JCR2021)是7.465,2021年影响因子6.054,2020年影响因子4.063。
关于此刊的具体情况,大家可以看看:
Circulation-Genomic and Precision Medicine 的收稿范围,期刊是如此介绍的(截取部分内容),详情请阅读:
https://www.ahajournals.org/circgen/about
Circulation: Genomic and Precision Medicineconsiders all types of original research articles, including studies conducted in human subjects, laboratory animals, in vitro, and in silico. Articles may include investigations of: clinical genetics as applied to the diagnosis and management of monogenic or oligogenic cardiovascular disorders; the molecular basis of complex cardiovascular disorders, including genome-wide association studies, exome and genome sequencing-based association studies, coding variant association studies, genetic linkage studies, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics; integration of electronic health record data or patient-generated data with any of the aforementioned approaches, including phenome-wide association studies, or with environmental or lifestyle factors; pharmacogenomics; regulation of gene expression; gene therapy and therapeutic genomic editing; systems biology approaches to the diagnosis and management of cardiovascular disorders; novel methods to perform any of the aforementioned studies; and novel applications of precision medicine. Above all, we seek studies with relevance to human cardiovascular biology and disease.
期刊接受时间
-
Received June 3, 2021; accepted January 17, 2022
-
Received August 4, 2021; accepted February 1, 2022
-
Received September 12, 2021; accepted November 24, 2021
期刊年发文量
对于 Circulation-Genomic and Precision Medicine 的发文量,2018年发文80篇,2019年发文50篇,2020年发文60多篇,2021年发文60多篇,截止2022年8月3日已发文20多篇。
影响因子
即时影响因子计算发现,2022年8月3日,3.265分。
此图为“51选刊”截图
如果还没有注册过账户,只需点击“register here”注册账户即可!
有7+分以上发表要求的,来看看这个潜力股的SCI期刊吧!
版权声明:本文转自“51选刊”,文章转载只为学术传播,不代表本号观点,无商业用途,版权归原作者所有,如涉及侵权问题,请联系我们,我们将及时修改或删除。
添加微信获取最新优惠、出版政策、课程直播信息,随时咨询客服/编辑,了解更多实时资讯